A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: inform (370), keep informed (185), keep posted (171), modernize (10), revise (100), renew (33)

Norma Diaper, lead clinical educator

Description
NIHR Southampton Clinical Research Facility Auto Generated Title As lead clinical educator, Norma caters for the education and training needs of
Url
/ClinicalResearchinSouthampton/Our-people/Clinical-research-facility-people/Norma-Diaper,-lead-clinical-educator.aspx

Appendix E - HBIG 500 IU sexual exposure risk assessment and prescription form

Description
HBIG,IU,sexual exposure
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixE-HBIG500IUSexualExposureRiskAssessmentandPrescriptionForm.pdf

Appendix D - HBIG 500 IU NSI risk assessment and prescription form

Description
Accidental exposure to blood or other body fluids: risk assessment for post-exposure prophylaxis (PEP) with Hepatitis B Immunoglobulin (HBIG) and
Url
/Media/UHS-website-2019/Docs/Post-Exposure-Prophylaxis-Policy/AppendixD-HBIG500IUNSIRiskAssessmentandPrescriptionForm.pdf

Clinical case tutorial key learning points

Description
Auto Generated Title The menopause and peri-menopause are common presentations in primary care. We have provided two publications on the
Url
/HealthProfessionals/BiochemistrytutorialforGPs/Clinicalcasetutorial/Clinicalcasetutorialkeylearningpoints.aspx

Remuneration & Appointment Committee ToR March 2026

Description
Remuneration and Appointment Committee Terms of Reference Date Issued: 10 March 2026 Review Date: Mar
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Remuneration-Appointment-Committee-ToR-March-2026.pdf

Capsule endoscopy – aftercare advice - patient information

Description
This factsheet explains what to expect after having a capsule endoscopy.
Url
/Media/UHS-website-2019/Patientinformation/Endoscopy/Capsule-endoscopy-–-aftercare-advice-1338-PIL.pdf

Breastfeeding support information leaflet

Description
National and local contacts, and local support groups for breastfeeding.
Url
/Media/UHS-website-2019/Docs/Services/Maternity/Breastfeeding-support-information-leaflet.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen This regimen is
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

InP RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Ver1.1

Description
Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE-RITUXIMAB (RIVE) Inpatient Regimen Regimen Lymphoma – InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab Indication • Non Hodgkin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-RIVE-Epirubicin-Etoposide-Ifosfamide-Rituximab.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description
Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be available
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf
301 to 310 of 673
Previous … 29 30 31 32 33 … Next